Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Riordan NH, Morales I, Fernández G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Rodriguez JP

Open source

DOI
10.1186/s12967-021-02869-4
Published
2021 May 10
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-021-02869-4,
  title = {Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.},
  author = {Riordan NH and Morales I and Fernández G and Allen N and Fearnot NE and Leckrone ME and Markovich DJ and Mansfield D and Avila D and Patel AN and Kesari S and Rodriguez JP},
  year = {2021},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-021-02869-4},
  url = {https://doi.org/10.1186/s12967-021-02869-4}
}

RIS

TY  - JOUR
TI  - Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.
AU  - Riordan NH
AU  - Morales I
AU  - Fernández G
AU  - Allen N
AU  - Fearnot NE
AU  - Leckrone ME
AU  - Markovich DJ
AU  - Mansfield D
AU  - Avila D
AU  - Patel AN
AU  - Kesari S
AU  - Rodriguez JP
PY  - 2021
JO  - Journal of translational medicine
DO  - 10.1186/s12967-021-02869-4
UR  - https://doi.org/10.1186/s12967-021-02869-4
ER  - 

APA

NH, R., I, M., G, F., N, A., NE, F., ME, L., DJ, M., D, M., D, A., AN, P., S, K., & JP, R. (2021). Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.. Journal of translational medicine. https://doi.org/10.1186/s12967-021-02869-4

Source records